vs

Side-by-side financial comparison of GUESS INC (GES) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.

GUESS INC is the larger business by last-quarter revenue ($791.4M vs $336.6M, roughly 2.4× Guardian Pharmacy Services, Inc.). Guardian Pharmacy Services, Inc. runs the higher net margin — 4.0% vs 3.2%, a 0.8% gap on every dollar of revenue. On growth, GUESS INC posted the faster year-over-year revenue change (7.2% vs 2.2%).

Guess?, Inc. is an American clothing company, notable for its black-and-white advertisements. It licenses its brand on other fashion accessories, such as watches, jewelry, perfumes, bags and shoes.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

GES vs GRDN — Head-to-Head

Bigger by revenue
GES
GES
2.4× larger
GES
$791.4M
$336.6M
GRDN
Growing faster (revenue YoY)
GES
GES
+5.0% gap
GES
7.2%
2.2%
GRDN
Higher net margin
GRDN
GRDN
0.8% more per $
GRDN
4.0%
3.2%
GES

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
GES
GES
GRDN
GRDN
Revenue
$791.4M
$336.6M
Net Profit
$25.6M
$13.5M
Gross Margin
42.5%
22.7%
Operating Margin
2.9%
5.3%
Net Margin
3.2%
4.0%
Revenue YoY
7.2%
2.2%
Net Profit YoY
209.6%
46.1%
EPS (diluted)
$0.48
$0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GES
GES
GRDN
GRDN
Q1 26
$336.6M
Q4 25
$791.4M
$397.6M
Q3 25
$772.9M
$377.4M
Q2 25
$647.8M
$344.3M
Q1 25
$932.3M
$329.3M
Q4 24
$738.5M
Q3 24
$732.6M
$314.4M
Q2 24
$591.9M
Net Profit
GES
GES
GRDN
GRDN
Q1 26
$13.5M
Q4 25
$25.6M
$20.9M
Q3 25
$6.2M
$9.8M
Q2 25
$-32.9M
$9.0M
Q1 25
$81.4M
$9.4M
Q4 24
$-23.4M
Q3 24
$-10.6M
$-122.0M
Q2 24
$13.0M
Gross Margin
GES
GES
GRDN
GRDN
Q1 26
22.7%
Q4 25
42.5%
21.5%
Q3 25
42.5%
19.8%
Q2 25
39.9%
19.8%
Q1 25
44.1%
19.5%
Q4 24
43.6%
Q3 24
43.7%
19.4%
Q2 24
41.9%
Operating Margin
GES
GES
GRDN
GRDN
Q1 26
5.3%
Q4 25
2.9%
7.7%
Q3 25
2.3%
4.3%
Q2 25
-5.1%
3.7%
Q1 25
11.1%
3.9%
Q4 24
5.7%
Q3 24
6.5%
-33.3%
Q2 24
-3.4%
Net Margin
GES
GES
GRDN
GRDN
Q1 26
4.0%
Q4 25
3.2%
5.3%
Q3 25
0.8%
2.6%
Q2 25
-5.1%
2.6%
Q1 25
8.7%
2.9%
Q4 24
-3.2%
Q3 24
-1.4%
-38.8%
Q2 24
2.2%
EPS (diluted)
GES
GES
GRDN
GRDN
Q1 26
$0.21
Q4 25
$0.48
Q3 25
$0.12
Q2 25
$-0.65
Q1 25
$1.29
Q4 24
$-0.47
Q3 24
$-0.28
Q2 24
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GES
GES
GRDN
GRDN
Cash + ST InvestmentsLiquidity on hand
$154.2M
$64.9M
Total DebtLower is stronger
$299.5M
Stockholders' EquityBook value
$508.5M
$232.4M
Total Assets
$3.0B
$426.9M
Debt / EquityLower = less leverage
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GES
GES
GRDN
GRDN
Q1 26
$64.9M
Q4 25
$154.2M
$65.6M
Q3 25
$189.6M
$36.5M
Q2 25
$151.2M
$18.8M
Q1 25
$187.7M
$14.0M
Q4 24
$140.9M
Q3 24
$218.9M
$37.2M
Q2 24
$241.7M
Total Debt
GES
GES
GRDN
GRDN
Q1 26
Q4 25
$299.5M
$0
Q3 25
$258.4M
Q2 25
$241.7M
Q1 25
$150.7M
Q4 24
$238.3M
Q3 24
$187.8M
$34.3M
Q2 24
$196.9M
Stockholders' Equity
GES
GES
GRDN
GRDN
Q1 26
$232.4M
Q4 25
$508.5M
$217.9M
Q3 25
$487.6M
$195.5M
Q2 25
$483.6M
$179.7M
Q1 25
$505.0M
$163.2M
Q4 24
$450.7M
Q3 24
$491.2M
$133.9M
Q2 24
$565.5M
Total Assets
GES
GES
GRDN
GRDN
Q1 26
$426.9M
Q4 25
$3.0B
$412.7M
Q3 25
$3.0B
$390.0M
Q2 25
$2.9B
$356.3M
Q1 25
$2.8B
$334.0M
Q4 24
$2.8B
Q3 24
$2.8B
$348.0M
Q2 24
$2.7B
Debt / Equity
GES
GES
GRDN
GRDN
Q1 26
Q4 25
0.59×
0.00×
Q3 25
0.53×
Q2 25
0.50×
Q1 25
0.30×
Q4 24
0.53×
Q3 24
0.38×
0.26×
Q2 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GES
GES
GRDN
GRDN
Operating Cash FlowLast quarter
$-39.5M
$6.1M
Free Cash FlowOCF − Capex
$-56.3M
FCF MarginFCF / Revenue
-7.1%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
-1.54×
0.45×
TTM Free Cash FlowTrailing 4 quarters
$62.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GES
GES
GRDN
GRDN
Q1 26
$6.1M
Q4 25
$-39.5M
$34.6M
Q3 25
$74.9M
$28.2M
Q2 25
$-73.4M
$19.9M
Q1 25
$183.2M
$17.6M
Q4 24
$-83.3M
Q3 24
$44.7M
Q2 24
$-22.9M
Free Cash Flow
GES
GES
GRDN
GRDN
Q1 26
Q4 25
$-56.3M
Q3 25
$53.4M
$24.2M
Q2 25
$-95.3M
Q1 25
$160.7M
Q4 24
$-105.4M
Q3 24
$24.3M
Q2 24
$-44.0M
FCF Margin
GES
GES
GRDN
GRDN
Q1 26
Q4 25
-7.1%
Q3 25
6.9%
6.4%
Q2 25
-14.7%
Q1 25
17.2%
Q4 24
-14.3%
Q3 24
3.3%
Q2 24
-7.4%
Capex Intensity
GES
GES
GRDN
GRDN
Q1 26
Q4 25
2.1%
Q3 25
2.8%
1.1%
Q2 25
3.4%
Q1 25
2.4%
Q4 24
3.0%
Q3 24
2.8%
Q2 24
3.6%
Cash Conversion
GES
GES
GRDN
GRDN
Q1 26
0.45×
Q4 25
-1.54×
1.65×
Q3 25
12.00×
2.87×
Q2 25
2.21×
Q1 25
2.25×
1.86×
Q4 24
Q3 24
Q2 24
-1.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GES
GES

Products$760.3M96%
Royalty$31.1M4%

GRDN
GRDN

Segment breakdown not available.

Related Comparisons